Tekla Life Sciences Investors
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 13 | Q3 13 | Q1 14 | Q3 14 | Q1 15 | Q3 15 | Q1 16 | Q3 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q3 23 | Q4 23 | Q1 24 | Q3 24 | Q1 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | 100.0% | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 0.0% | – | 0.0% | – | 0.0% | – | 0.0% | 540,699.3% | 270.3% | 235.9% | 244.7% | 244.7% | 235.9% | 201.8% | 201.8% | 168.2% | 168.2% | 11.0% | – | 16.5% | – | 10.2% | – | 19.4% | – | 28.6% | – | 12.2% | – | 137.5% | 8.8% | 122.6% | 122.6% | 147.6% | 13.9% | 21.0% | 6.5% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -540,599.3% | -170.3% | 100.0% | -144.7% | 100.0% | -135.9% | 100.0% | -101.8% | 100.0% | -68.2% | 89.0% | – | 83.5% | – | 89.8% | – | 80.6% | – | 71.4% | 100.0% | 87.8% | 100.0% | 100.0% | 91.2% | 100.0% | 100.0% | 100.0% | 86.1% | 79.0% | 93.5% | |
| – | – | – | 0.0% | – | 0.0% | – | 0.0% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 739.3% | 691.1% | 481.7% | 583.5% | 588.5% | 380.2% | 384.1% | 343.6% | 325.2% | 335.4% | 335.4% | 58.4% | 278.6% | 33.3% | 284.7% | 36.2% | 238.6% | 30.9% | 200.2% | 26.9% | 0.0% | – | 0.0% | – | 0.0% | – | 0.0% | – | 0.0% | 182.2% | 6.7% | 148.8% | 148.8% | 6.7% | 131.2% | 131.2% | 165.3% | 15.0% | 6.4% | 6.8% | |
| 10,757.7% | 21,035.9% | 7,529.2% | 12,963.8% | 18,566.2% | 6,156.0% | 9,783.4% | 7,851.2% | 3,288.1% | 335.4% | 4,584.9% | 65.0% | 278.6% | 40.1% | 284.7% | 42.7% | 238.6% | 36.9% | 200.2% | 32.1% | 0.1% | – | 0.3% | – | 0.1% | – | 0.1% | – | 0.4% | 1,887.4% | 68.9% | 1,652.0% | 148.8% | 130.0% | 131.6% | 131.6% | 166.2% | 345.7% | -1,062.8% | -42.4% | |
| -639.3% | -591.1% | -381.7% | -483.5% | -488.5% | -280.2% | -284.1% | -243.6% | -225.2% | -235.4% | -235.4% | -99.9% | -178.6% | -92.4% | -184.7% | -78.3% | -138.6% | -58.5% | -100.2% | – | 133.7% | – | 562.9% | – | 108.7% | – | 206.3% | – | -750.1% | -82.2% | -130.5% | -48.8% | -48.8% | -38.7% | -31.6% | -31.6% | -66.2% | -259.5% | 1,141.8% | 135.9% | |
| – | – | – | 0.0% | – | 0.0% | – | 0.0% | – | 0.0% | 9,840,577.0% | 0.0% | 1,801.7% | 0.0% | 5,080.6% | – | 3,332.4% | – | 2,287.5% | – | 135.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 10,858.1% | 21,136.1% | 7,629.4% | 13,063.9% | 18,666.3% | -6,056.0% | -9,683.6% | 7,951.2% | 3,388.2% | 4,684.9% | 4,684.7% | -1,107.4% | -1,980.2% | 2,447.9% | 4,895.9% | -1,960.9% | -3,471.0% | -1,392.5% | -2,387.7% | – | 133.8% | – | 562.8% | – | 108.7% | – | 206.4% | – | -750.1% | -1,787.5% | -130.5% | 1,752.1% | 1,752.1% | -38.7% | 2,433.4% | 2,433.4% | 1,830.0% | -259.5% | 1,141.8% | 135.9% | |
| 11,496.2% | 21,727.5% | 8,011.3% | 13,546.8% | 19,154.2% | -5,775.8% | -9,399.5% | 8,194.8% | 3,613.1% | 0.0% | 4,919.9% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | 0.0% | – | 0.0% | – | 0.0% | – | 0.0% | – | 0.0% | -1,705,221.8% | -3.0% | 1,800,863.6% | 2.3% | -0.1% | 1,232.5% | -15.8% | – | – | – | – | |
| 10,858.1% | 21,136.1% | 7,629.4% | 13,063.9% | 18,666.3% | -6,056.0% | -9,683.6% | 7,951.2% | 3,388.2% | 4,684.9% | 4,684.7% | -1,107.4% | -1,980.2% | 2,447.9% | 4,895.9% | -1,960.9% | -3,471.0% | -1,392.5% | -2,387.7% | – | 133.8% | – | 562.8% | – | 108.7% | – | 206.4% | – | -750.1% | -1,787.5% | -130.5% | 1,752.1% | 1,752.1% | -38.7% | 2,433.4% | 2,433.4% | 1,830.0% | -259.5% | 1,141.8% | 135.9% | |
| 11,497.0% | 21,727.5% | 8,011.3% | 13,547.3% | 19,154.6% | -5,775.8% | -9,399.5% | 8,194.8% | 3,613.3% | – | 4,920.1% | – | -3,781.9% | – | 9,976.5% | – | -6,803.4% | – | -4,675.2% | – | 133.7% | – | 562.9% | – | 108.7% | – | 206.3% | – | -750.1% | -1,705.2% | -127.5% | 1,800.8% | 1,752.1% | -38.7% | 4,898.5% | 4,866.8% | 1,830.0% | -259.5% | 1,141.8% | 135.9% |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.